Literature DB >> 15855451

Can we capitalize on the virtues of vaccines? Insights from the polio eradication initiative.

R Bruce Aylward1, David L Heymann.   

Abstract

Twenty-five years after the eradication of smallpox, the ongoing effort to eradicate poliomyelitis has grown into the largest international health initiative ever undertaken. By 2004, however, the polio eradication effort was threatened by a challenge regularly faced by public health policymakers everywhere-misperception about the benefits and risks of vaccines. The propagation of false rumors about oral poliovirus vaccine safety led to the reinfection of 13 previously polio-free countries and the largest polio epidemic in Africa in recent years. With deft management of such challenges by local, national, and international health authorities, poliomyelitis, a disease that threatened children everywhere just 2 generations ago, could soon be relegated to history like smallpox before it.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855451      PMCID: PMC1449254          DOI: 10.2105/AJPH.2004.055897

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  19 in total

1.  Virology. Poliomyelitis eradication--a dangerous endgame.

Authors:  Neal Nathanson; Paul Fine
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Progress in certification of poliomyelitis eradication and in laboratory containment of wild poliovirus.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2003-11-28

3.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

4.  Progress towards global eradication of poliomyelitis, 2003 and January-April 2004.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2004-06-18

5.  Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission.

Authors:  R Bruce Aylward; Stephen L Cochi
Journal:  Bull World Health Organ       Date:  2004-02-26       Impact factor: 9.408

6.  Getting polio eradication back on track in Nigeria.

Authors:  Ebrahim Samba; Francis Nkrumah; Rose Leke
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

7.  Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Authors:  Melinda Wharton; Raymond A Strikas; Rafael Harpaz; Lisa D Rotz; Benjamin Schwartz; Christine G Casey; Michele L Pearson; Larry J Anderson
Journal:  MMWR Recomm Rep       Date:  2003-04-04

8.  Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus.

Authors:  Olen Kew; Victoria Morris-Glasgow; Mauricio Landaverde; Cara Burns; Jing Shaw; Zacarías Garib; Jean André; Elizabeth Blackman; C Jason Freeman; Jaume Jorba; Roland Sutter; Gina Tambini; Linda Venczel; Cristina Pedreira; Fernando Laender; Hiroyuki Shimizu; Tetsuo Yoneyama; Tatsuo Miyamura; Harrie van Der Avoort; M Steven Oberste; David Kilpatrick; Stephen Cochi; Mark Pallansch; Ciro de Quadros
Journal:  Science       Date:  2002-03-14       Impact factor: 47.728

9.  Persistence of vaccine-derived polioviruses among immunodeficient persons with vaccine-associated paralytic poliomyelitis.

Authors:  Nino Khetsuriani; D Rebecca Prevots; Linda Quick; Melissa E Elder; Mark Pallansch; Olen Kew; Roland W Sutter
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

Review 10.  Global health goals: lessons from the worldwide effort to eradicate poliomyelitis.

Authors:  R Bruce Aylward; Arnab Acharya; Sarah England; Mary Agocs; Jennifer Linkins
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

View more
  8 in total

1.  Rumor surveillance in support of minimally invasive tissue sampling for diagnosing the cause of child death in low-income countries: A qualitative study.

Authors:  Md Saiful Islam; Abdullah Al-Masud; Maria Maixenchs; Saquina Cossa; Rui Guilaze; Kounandji Diarra; Issa Fofana; Faruqe Hussain; John Blevins; Ahoua Kone; Shams El Arifeen; Inácio Mandomando; Quique Bassat; Elizabeth O'Mara Sage; Emily S Gurley; Khátia Munguambe
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

Review 2.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

3.  Addressing the Vaccine Hesitancy Continuum: An Audience Segmentation Analysis of American Adults Who Did Not Receive the 2009 H1N1 Vaccine.

Authors:  Shoba Ramanadhan; Ezequiel Galarce; Ziming Xuan; Jaclyn Alexander-Molloy; Kasisomayajula Viswanath
Journal:  Vaccines (Basel)       Date:  2015-07-15

4.  The impact of seasonality on the dynamics and control of Ascaris lumbricoides infections.

Authors:  A J Cooper; T Déirdre Hollingsworth
Journal:  J Theor Biol       Date:  2018-05-22       Impact factor: 2.691

5.  A model of factors influencing COVID-19 vaccine acceptance: A synthesis of the theory of reasoned action, conspiracy theory belief, awareness, perceived usefulness, and perceived ease of use.

Authors:  Taslima Akther; Tasnima Nur
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

6.  The impact of COVID-19 on implementation of mass testing, treatment and tracking of malaria in rural communities in Ghana: A qualitative study.

Authors:  Ndong Ignatius Cheng; Philip Teg-Nefaah Tabong; Palmer Masumbe Netongo; Benedicta Ayiedu Mensah; Chuo Ennestine Chu; Effah-Baafi Yaw; Juliana Yartey Enos; Keziah Malm; Collins Stephen Ahorlu
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

Review 7.  Listening to the rumours: what the northern Nigeria polio vaccine boycott can tell us ten years on.

Authors:  Isaac Ghinai; Chris Willott; Ibrahim Dadari; Heidi J Larson
Journal:  Glob Public Health       Date:  2013-12-03

8.  Vaccine confidence: the keys to restoring trust.

Authors:  Selim Badur; Martin Ota; Serdar Öztürk; Richard Adegbola; Anil Dutta
Journal:  Hum Vaccin Immunother       Date:  2020-04-16       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.